Treatment of Anorexia (Loss of Appetite) with Unani medicine Jawarish Pudina

Clinical Validation of Unani Pharmacopoeial Formulation Jawarish Pudina in Du â??f al Ishtiha (Anorexia)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017800

Enrollment

240

Registered

2019-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R630- Anorexia

Interventions

Intervention1: Jawarish Pudina: 5gms orally twice daily with water before meals for two weeks Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of any sex in the age group 18-65 years. 2. Patients having Du â??f al Ishtiha (Anorexia) with SNAQ score

Exclusion criteria

Exclusion criteria: 1. Patients having Anorexia nervosa 2. Patients having any acute systemic disease, T.B., Uncontrolled Diabetes etc. 3. Patients requiring long term therapy e.g. Hepatic, Renal or Cardiac Ailments 4. History of hypersensitivity to study drug or any of its ingredients. 5. History of addiction (Alcohol, Drugs) 6. Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Improvement in sign and symptoms of Du â??f al Ishtiha (Anorexia)Timepoint: 2weeks	—

Secondary

Measure	Time frame
Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment	—

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine

ccrum507@rediffmail.com9213511298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026